p27 as a target for cancer therapeutics

被引:146
作者
Blain, SW
Scher, HI
Cordon-Cardo, C
Koff, A
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Cell Biol & Genet, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA
[4] Mem Sloan Kettering Canc Ctr, Dept Mol Biol, New York, NY 10021 USA
关键词
D O I
10.1016/S1535-6108(03)00026-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:111 / 115
页数:5
相关论文
共 45 条
  • [1] Inhibition of cyclin-dependent kinase activity and induction of apoptosis by preussin in human tumor cells
    Achenbach, TV
    Slater, EP
    Brummerhop, H
    Bach, T
    Müller, R
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (10) : 2794 - 2801
  • [2] Overexpressed cyclin D3 contributes to retaining the growth inhibitor p27 in the cytoplasm of thyroid tumor cells
    Baldassarre, G
    Belletti, B
    Bruni, P
    Boccia, A
    Trapasso, F
    Pentimalli, F
    Barone, MV
    Chiappetta, G
    Vento, MT
    Spiezia, S
    Fusco, A
    Viglietto, G
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (07) : 865 - 874
  • [3] Interleukin-7 promotes survival and cell cycle progression of T-cell acute lymphoblastic leukemia cells by down-regulating the cyclin-dependent kinase inhibitor p27kip1
    Barata, JT
    Cardoso, AA
    Nadler, LM
    Boussiotis, VA
    [J]. BLOOD, 2001, 98 (05) : 1524 - 1531
  • [4] p27 deficiency desensitizes Rb-/- cells to signals that trigger apoptosis during pituitary tumor development
    Carneiro, C
    Jiao, MS
    Hu, M
    Shaffer, D
    Park, M
    Pandolfi, PP
    Cordon-Cardo, C
    Koff, A
    [J]. ONCOGENE, 2003, 22 (03) : 361 - 369
  • [5] Chauffert B, 1999, B CANCER, V86, P97
  • [6] S-Phase kinase-associated protein 2 expression in non-Hodgkin's lymphoma inversely correlates with p27 expression and defines cells in S phase
    Chiarle, R
    Fan, Y
    Piva, R
    Boggino, H
    Skolnik, J
    Novero, D
    Palestro, G
    De Wolf-Peeters, C
    Chilosi, M
    Pagano, M
    Inghirami, G
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2002, 160 (04) : 1457 - 1466
  • [7] Ciaparrone M, 1998, CANCER RES, V58, P114
  • [8] Inhibin and p27 interact to regulate gonadal tumorigenesis
    Cipriano, SC
    Chen, L
    Burns, KH
    Koff, A
    Matzuk, MM
    [J]. MOLECULAR ENDOCRINOLOGY, 2001, 15 (06) : 985 - 996
  • [9] Distinct altered patterns of p27KIP1 gene expression in benign prostatic hyperplasia and prostatic carcinoma
    Cordon-Cardo, C
    Koff, A
    Drobnjak, M
    Capodieci, P
    Osman, I
    Millard, SS
    Gaudin, PB
    Fazzari, M
    Zhang, ZF
    Massague, J
    Scher, HI
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (17): : 1284 - 1291
  • [10] E1A signaling to p53 involves the p19ARF tumor suppressor
    de Stanchina, E
    McCurrach, ME
    Zindy, F
    Shieh, SY
    Ferbeyre, G
    Samuelson, AV
    Prives, C
    Roussel, MF
    Sherr, CJ
    Lowe, SW
    [J]. GENES & DEVELOPMENT, 1998, 12 (15) : 2434 - 2442